{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/C",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "CARDIOVASCULAR SYSTEM" , "@language" : "en" } ,        { "@value" : "Kardiovaskul\u00E1rn\u00ED syst\u00E9m" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "CARDIAC THERAPY" , "@language" : "en" } ,        { "@value" : "Kardiaka" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C01A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Srde\u010Dn\u00ED glykosidy" , "@language" : "cs" } ,        { "@value" : "CARDIAC GLYCOSIDES" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C01A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C01AA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Digitalis glycosides" , "@language" : "en" } ,        { "@value" : "Digitalisov\u00E9 glykosidy" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C01AA" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/C01AA05",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/C01AA" ,        "http://linked.opendata.cz/resource/ATC/C01" ,        "http://linked.opendata.cz/resource/ATC/C" ,        "http://linked.opendata.cz/resource/ATC/C01A" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Digoxin" , "@language" : "cs" } ,        { "@value" : "Digoxin" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "C01AA05" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001430",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Heart block" , "@language" : "en" } ,        { "@value" : "Srdce - blok\u00E1da" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003541",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Tachycardia, ventricular" , "@language" : "en" } ,        { "@value" : "Komorov\u00E1 tachykardie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003118",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Fibrilace komor" , "@language" : "cs" } ,        { "@value" : "Ventricular fibrillation" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000687",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Cardiomyopathy, hypertrophic" , "@language" : "en" } ,        { "@value" : "Kardiomyopatie hypertrofick\u00E1" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000375",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Amyloid\u00F3za" , "@language" : "cs" } ,        { "@value" : "Amyloidosis" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002363",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Konstriktivn\u00ED perikarditida" , "@language" : "cs" } ,        { "@value" : "Pericarditis, constrictive" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0006386",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Digoxin" , "@language" : "cs" } ,        { "@value" : "Digoxin" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001326" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0003471" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000001430" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000687" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000375" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003118" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002363" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003541" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/DIGOXIN-0-125-LECIVA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0006386" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "DIGOXIN 0,125 L\u00C9\u010CIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C01AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0083318" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001326",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Anti-arrhythmia agents" , "@language" : "en" } ,        { "@value" : "Antiarytmika" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0003471",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Kardiotonika" , "@language" : "cs" } ,        { "@value" : "Cardiotonic agents" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Enzymy - inhibitory" , "@language" : "cs" } ,        { "@value" : "Enzyme inhibitors" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0083318",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "DIGOXIN 0,125 L\u00C9\u010CIVA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/C01AA05" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CARDIACA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC158852_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.125MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Srde\u010Dn\u00ED selh\u00E1v\u00E1n\u00ED u\u00A0hypertrofick\u00FDch a\u00A0dilatovan\u00FDch srdc\u00ED p\u0159i\u00A0chronick\u00E9m tlakov\u00E9m a\u00A0objemov\u00E9m p\u0159et\u00ED\u017Een\u00ED (arteri\u00E1ln\u00ED hypertenze, aort\u00E1ln\u00ED nebo mitr\u00E1ln\u00ED insuficience, chronick\u00E1 ischemick\u00E1 choroba srde\u010Dn\u00ED), zvl\u00E1\u0161t\u011B je-li p\u0159\u00EDtomna fibrilace s\u00EDn\u00ED s\u00A0rychlou odpov\u011Bd\u00ED komor. \nDlouhodob\u00E9 pod\u00E1v\u00E1n\u00ED digoxinu je\u00A0indikov\u00E1no u\u00A0chronick\u00E9ho srde\u010Dn\u00EDho selh\u00E1n\u00ED (p\u0159i dobr\u00E9 kompenzaci trvaj\u00EDc\u00ED n\u011Bkolik m\u011Bs\u00EDc\u016F, zejm\u00E9na p\u0159i\u00A0nejasn\u00E9 p\u016Fvodn\u00ED indikaci digoxinu, je mo\u017En\u00E9 opatrn\u00E9 vysazen\u00ED digoxinu za\u00A0pe\u010Dliv\u00E9 klinick\u00E9 a\u00A0laboratorn\u00ED kontroly zejm\u00E9na u nemocn\u00FDch, u\u00A0kter\u00FDch je vy\u0161\u0161\u00ED riziko intoxikace).\nFibrilace s\u00EDn\u00ED s rychlou odpov\u011Bd\u00ED komor, zejm\u00E9na p\u0159i sou\u010Dasn\u00E9m srde\u010Dn\u00EDm selh\u00E1n\u00ED (pokud se ned\u00E1 p\u0159\u00EDmo p\u0159ednost kardioverzi). \nP\u0159\u00EDpravek je ur\u010Den k\u00A0l\u00E9\u010Db\u011B dosp\u011Bl\u00FDch a\u00A0d\u011Bt\u00ED od\u00A03\u00A0let.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 29.68000030517578 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 36.88999938964844 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 30X0.125MG" , "@language" : "cs" } ] }] }